MaxCyte (MXCT) has released an update.
MaxCyte, Inc., a leader in cell-engineering platform technologies, has announced their participation in the 44th Annual William Blair Growth Stock Conference on June 5th. The event will feature a live webcast, available on the company’s investor relations website. MaxCyte specializes in technologies that support the development of advanced cell-based therapies and is known for its ExPERT™ platform, which aids in the cell therapy market from research to commercialization.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
